VAXCYTE INC's ticker is PCVX and the CUSIP is 92243G108. A total of 187 filers reported holding VAXCYTE INC in Q1 2023. The put-call ratio across all filers is 0.60 and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $13,561,750 | +12.2% | 266,021 | +9.9% | 0.10% | +1.0% |
Q2 2023 | $12,089,374 | +253.6% | 242,078 | +165.4% | 0.10% | +215.2% |
Q1 2023 | $3,418,700 | -54.6% | 91,214 | -41.9% | 0.03% | -47.6% |
Q4 2022 | $7,534,048 | +1267.3% | 157,123 | +583.8% | 0.06% | +1160.0% |
Q3 2022 | $551,000 | – | 22,979 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Abingworth LLP | 4,168,718 | $82,124,000 | 28.36% |
Medicxi Ventures Management (Jersey) Ltd | 1,887,478 | $37,277,000 | 21.71% |
Pivotal bioVenture Partners Investment Advisor LLC | 1,405,421 | $27,757,000 | 8.90% |
FRAZIER MANAGEMENT LLC | 2,309,554 | $45,614,000 | 3.66% |
RA Capital Management | 3,865,808 | $76,350,000 | 1.15% |
TPG Group Holdings (SBS) Advisors, Inc. | 4,558,475 | $90,030,000 | 1.05% |
Soleus Capital Management, L.P. | 293,650 | $5,800,000 | 1.04% |
Opaleye Management Inc. | 357,800 | $7,067,000 | 1.04% |
SABBY MANAGEMENT, LLC | 178,992 | $3,535,000 | 0.69% |
Penn Mutual Asset Management | 22,227 | $439,000 | 0.50% |